{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.0/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Alfentanil",
            "Path": "../../Alfentanil-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Alfentanil",
                "Simulation": "Ferrier 1985, Alfentanil iv 0.05 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 1997, Alfentanil iv 0.02 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2004, Alfentanil iv 0.015 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2011, Alfentanil iv 0.015 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2011, Alfentanil po 0.075 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2011b, Alfentanil IV 1 mg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2012, Alfentanil iv 0.02 mg/kg",
                "SectionReference": "ct-profiles-model-verification"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Kharasch 2012, Alfentanil po 0.043 mg/kg",
                "SectionReference": "ct-profiles-model-verification"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Meistelman 1987, 20µg/kg, adult male individual",
                "SectionReference": "ct-profiles-model-building"
            },
            {
                "Project": "Alfentanil",
                "Simulation": "Phimmasone 2001, Alfentanil iv 0.015 mg/kg",
                "SectionReference": "ct-profiles-model-building"
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plot for concentration in plasma",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "Intravenous administration",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Ferrier 1985, Alfentanil iv 0.05 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Ferrier 1985 - healthy control patients - Alfentanil - IV - 0.05 mg/kg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 1997, Alfentanil iv 0.02 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Alfentanil - IV - 20 µg/kg - Plasma - agg. (n=9)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2004, Alfentanil iv 0.015 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2011, Alfentanil iv 0.015 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2011b, Alfentanil IV 1 mg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Kharasch 2011b - Alfentanil IV Control sequential - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
                                    "Kharasch 2011b - Alfentanil IV Control simultaneous - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
                                    "Kharasch 2011b - Alfentanil IV Grapefruit coadmin sequential - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
                                    "Kharasch 2011b - Alfentanil IV Grapefruit coadmin simultaneous - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)"
                                ],
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2012, Alfentanil iv 0.02 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch2012_Alfentanil_alone_IV",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Meistelman 1987, 20µg/kg, adult male individual",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Meistelman_1987_Figure_1 adults",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Phimmasone 2001, Alfentanil iv 0.015 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2004 - po #1 (60 µg/kg) Control (Perpetrator Placebo) - Alfentanil - PO - 60 µg/kg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2011, Alfentanil po 0.075 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Kharasch 2011b - Alfentanil PO Control sequential - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
                                    "Kharasch 2011b - Alfentanil PO Control simultaneous - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)"
                                ],
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Alfentanil",
                                "Simulation": "Kharasch 2012, Alfentanil po 0.043 mg/kg",
                                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch2012_Alfentanil_alone_po",
                                "Color": "#FF0000"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Alfentanil",
            "Name": "Alfentanil",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Alfentanil",
            "Name": "Solution",
            "Type": "Formulation",
            "SectionReference": "final-input-parameters"
        }
    ],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Reference": "methods",
            "Title": "Methods",
            "Sections": [
                {
                    "Reference": "modeling-strategy",
                    "Title": "Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Reference": "data",
                    "Title": "Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Reference": "model-parameters-and-assumptions",
                    "Title": "Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Reference": "results-and-discussion",
            "Title": "Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Reference": "final-input-parameters",
                    "Title": "Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Reference": "diagnostics-plots",
                    "Title": "Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Reference": "ct-profiles",
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Reference": "ct-profiles-model-building",
                            "Title": "Model Building"
                        },
                        {
                            "Reference": "ct-profiles-model-verification",
                            "Title": "Model Verification"
                        }
                    ]
                }
            ]
        },
        {
            "Reference": "conclusion",
            "Title": "Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Reference": "main-references",
            "Title": "References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}